These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tissue kallikrein-modified human endothelial progenitor cell implantation improves cardiac function via enhanced activation of akt and increased angiogenesis. Yao Y, Sheng Z, Li Y, Fu C, Ma G, Liu N, Chao J, Chao L. Lab Invest; 2013 May; 93(5):577-91. PubMed ID: 23508045 [Abstract] [Full Text] [Related]
8. Kallikrein/kinin protects against myocardial apoptosis after ischemia/reperfusion via Akt-glycogen synthase kinase-3 and Akt-Bad.14-3-3 signaling pathways. Yin H, Chao L, Chao J. J Biol Chem; 2005 Mar 04; 280(9):8022-30. PubMed ID: 15611141 [Abstract] [Full Text] [Related]
9. Autologous transplantation of endothelial progenitor cells genetically modified by adeno-associated viral vector delivering insulin-like growth factor-1 gene after myocardial infarction. Sen S, Merchan J, Dean J, Ii M, Gavin M, Silver M, Tkebuchava T, Yoon YS, Rasko JE, Aikawa R. Hum Gene Ther; 2010 Oct 04; 21(10):1327-34. PubMed ID: 20497036 [Abstract] [Full Text] [Related]
10. Tissue kallikrein elicits cardioprotection by direct kinin b2 receptor activation independent of kinin formation. Chao J, Yin H, Gao L, Hagiwara M, Shen B, Yang ZR, Chao L. Hypertension; 2008 Oct 04; 52(4):715-20. PubMed ID: 18768400 [Abstract] [Full Text] [Related]
20. Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Chimenti I, Smith RR, Li TS, Gerstenblith G, Messina E, Giacomello A, Marbán E. Circ Res; 2010 Mar 19; 106(5):971-80. PubMed ID: 20110532 [Abstract] [Full Text] [Related] Page: [Next] [New Search]